Sonographic Evaluation of Patients With Carpal Tunnel Syndrome Following Steroid Injection
1 other identifier
interventional
54
1 country
1
Brief Summary
The objective of this study was to assess sonographic changes of the median nerve after steroid injection for carpal tunnel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
April 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedApril 27, 2017
February 1, 2017
4.8 years
February 16, 2017
April 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cross sectional area
The CSA of the median nerve was measured at 2 levels: at the carpal tunnel inlet (CSA-I; immediately prior to the proximal margin of the flexor retinaculum) and in the mid-carpal tunnel (CSA-M; at the level of the pisiform bone and scaphoid tubercle)
12 weeks
Secondary Outcomes (6)
flattening ratio
2, 6, 12 weeks
Boston Carpal Tunnel Questionnaire (BQ)
2, 6, 12 weeks
Median nerve distal motor latency
2, 6, 12 weeks
sensory nerve conduction velocity
2, 6, 12 weeks
compound muscle action potential amplitude (CMAP)
2, 6, 12 weeks
- +1 more secondary outcomes
Study Arms (1)
steroid injection
EXPERIMENTALultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide
Interventions
ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide
Eligibility Criteria
You may qualify if:
- clinical diagnosis of CTS
- The diagnosis of CTS was confirmed by electrophysiological tests.
You may not qualify if:
- neurologic disorders that could mimic CTS such as cervical radiculopathy, polyneuropathy, proximal median nerve entrapment, or thoracic outlet syndrome
- history of distal radius fracture
- pregnancy or lactation
- regular use of systemic NSAIDs or corticosteroids
- known allergy to corticosteroids and local anesthetics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Teipei Veterans General Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jia chi Wang
Taipei Veteran General hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2017
First Posted
April 27, 2017
Study Start
April 1, 2013
Primary Completion
February 1, 2018
Study Completion
February 1, 2018
Last Updated
April 27, 2017
Record last verified: 2017-02